Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 17, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Reboxetine and Butyl-bromide: Drugs to solve sleep apnea issues

Longer gap between vaccine doses: Effective or not?

Aging control genes identified in Drosophila!

Reboxetine and Butyl-bromide: Drugs to solve sleep apnea issues
  • BiotechToday
  • World

Reboxetine and Butyl-bromide: Drugs to solve sleep apnea issues

BioTech Today July 8, 2021July 7, 2021

Shreyas bhat , DY Patil School of biotechnology and bioinformatics

What is sleep apnea?

Sleep apnea is a sleep disorder in which frequent on and off events of breathing take place repeatedly. If you snore loudly and feel tired even after sleeping for more than 8hrs, you might have sleep apnea.

The major types of sleep apnea are:

•       Obstructive sleep apnea:- the more common form that occurs when throat muscles relax

•       Central sleep apnea:- in which your brain doesn’t send proper signals to the muscles that control breathing into

•       Complex sleep apnea:-  Treatment-emergent central sleep apnea is the common term referred, which occurs when someone has both obstructive sleep apnea and central sleep apnea at the same time.

A team of researchers at the Institute for Sleep Health at Flinders UniversityAdelaide, Australia, have successfully cut down the severity of sleep apnea in people by 30 %. If untreated, it likely leads to dementia and depression, these patients are more likely to cause car crashes when compared to the population.

A team of researchers at the Institute for Sleep Health at Flinders University Adelaide, Australia, have successfully cut down the severity of sleep apnea in people by 30%.

The  potential remedy for sleep apnea        

A team of researchers R. Lim, L. Messineo, R. Grunstein, J. Carberry, D.J. Eckert in Australia have bought us one step closer by using already existing anticholinergic and antidepressants to check their efficacy in people with sleep apnea. The existing data suggested the use of two classes of drugs: reboxetine and butyl bromide that kept muscles active during sleep in people without sleep apnea which in turn increased or enhanced their breathing ability. Using these two drugs, researchers used a range of measuring instruments to quantify whether reboxetine and butyl bromide could target the major cause of sleep apnea. It includes balancing the electrical activity of muscles around the air canal, prevents the throat from collapsing why patients are sleeping, improving the breathing cycle during sleep.

Results showed these drugs enhanced muscle activity and reduced the severity of sleep apnea up to 30%.

There was a sign of improvement in every patient that went through this study. People’s oxygen intake improved, the number of breathing stoppages was a 3rd or less. Researchers are thrilled as treatment options for people with sleep apnea are limited and may be a sore trip for several patients.

These findings will allow researchers to redefine these types of drugs as they have a benefit to what has been discovered. To date, the most major therapy for sleep apnea includes wearing a mask while the patient is asleep or continuous positive airway therapy. However major population affected by sleep apnea find the existing treatments uncomfortable and 50% of the patients find it difficult to tolerate. Second-line therapies include mouthguards fitted by dentists, which are unpredictable and expensive.

Thus reboxetine and butyl bromide can be a breakthrough in treating sleep apnea. Both the drugs are being used in combination. Researchers are working on trying one drug at a time and different drugs from this category are also understudy for finding their potential and long-term use which would be a great sign of relief for millions of sleep apnea patients.

Also read: Clofoctol: A potential Antibiotic against SARS-CoV-2

References:

  1. Lim, R., Messineo, L., Grunstein, R. R., Carberry, J. C., & Eckert, D. J. (2021). The noradrenergic agent reboxetine plus antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: A double‐blind, placebo‐controlled, randomised crossover trial. The Journal of Physiology, JP281912. https://doi.org/10.1113/JP281912

Author info:

Shreyas bhat  currently pursuing MSc in Biotechnology from DY Patil School of Biotechnology and Bioinformatics. My area of interest include quantum physics, astronomy , biosciences which do not match with my qualification but science in general has a greater pull and always open to explore various branches of science.

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged air canal Anticholinergic antidepressant Brain breathing dementia depression disease drugs efficacy Medical Research Muscle NervousSystem neuroscience physiology Placebo research respiratory sleep Sleep disorders Throat

One thought on “Reboxetine and Butyl-bromide: Drugs to solve sleep apnea issues”

  1. Pingback: Understanding Pregnancy with PCOS - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Aging control genes identified in Drosophila!

BioTech Today July 8, 2021

Sneha Singhal, Jaypee Institute of information technology For examining the activity of aging control genes, scientists fed Drosophila (fruit fly) with antibiotics. Activities of most of the aging control genes get changed, and surprisingly, these antibiotics extended the lives of the flies. Drosophila’s life increased by six days after being fed antibiotics. 70% of the […]

Aging control genes

Related Post

  • BiotechToday
  • World

New Study Finds the Importance of Landscapes in Rewilding

bioxone April 30, 2021April 30, 2021

Sampriti Roy, University of Calcutta Reintroduction or ‘rewilding’, an approach to restoring the biodiversity of an area, is gaining increasing popularity worldwide. The aim of any rewilding event is to promote self-sustenance of an ecosystem, such that it has conditions that require minimal external maintenance. This approach is especially essential right now due to the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

World Sickle Cell Awareness Day 2021

BioTech Today June 19, 2021June 18, 2021

Sagnik Nag, Amity University, Kolkata World Sickle Cell Awareness Day is celebrated on June 19 every year to heighten awareness about the genetic disorder Sickle Cell Disease (SCD). The disease is naturally found in people from all over Africa, Southern America, Central America, Saudi Arabia, India, Northern Turkey, and in a few pockets of Italy. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Gel-mediated drug delivery- A breakthrough in treating Brain disorders

bioxone June 10, 2021June 12, 2021

Sampriti Roy, University of Calcutta When we see conventional drug administration, especially in cases of neurodegenerative diseases like Parkinson’s, the commonly prescribed drugs are those that require metabolism to be absorbed into the central nervous system. However, it has been found that the number of drugs reaching the brain after metabolism is very small. We […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy